» Articles » PMID: 19242642

Cardioprotection and Altered Mitochondrial Adenine Nucleotide Transport

Overview
Date 2009 Feb 27
PMID 19242642
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

It is becoming increasingly clear that mitochondrial dysfunction is critically important in myocardial ischemic injury, and that cardioprotective mechanisms must ultimately prevent or attenuate mitochondrial damage. Mitochondria are also essential for energy production, and therefore prevention of mitochondrial injury must not compromise oxidative phosphorylation during reperfusion. This review will focus on one mitochondrial mechanism of cardioprotection involving inhibition of adenine nucleotide transport across the outer mitochondria membrane under de-energized conditions. This slows ATP hydrolysis by the mitochondria, and would be expected to lower mitochondrial membrane potential during ischemia, to inhibit calcium uptake during ischemia, and potentially to reduce free radical generation during early reperfusion. Two interventions that similarly inhibit mitochondrial adenine nucleotide transport are Bcl-2 overexpression and GSK inhibition. A possible final common mechanism shared by both of these interventions is discussed.

Citing Articles

Roles of LncRNAs in Regulating Mitochondrial Dysfunction in Septic Cardiomyopathy.

Liu S, Chong W Front Immunol. 2021; 12:802085.

PMID: 34899764 PMC: 8652231. DOI: 10.3389/fimmu.2021.802085.


Calcium overload decreases net free radical emission in cardiac mitochondria.

Duong Q, Hoffman A, Zhong K, Dessinger M, Zhang Y, Bazil J Mitochondrion. 2020; 51:126-139.

PMID: 31982614 PMC: 7061345. DOI: 10.1016/j.mito.2020.01.005.


Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target.

Camara A, Zhou Y, Wen P, Tajkhorshid E, Kwok W Front Physiol. 2017; 8:460.

PMID: 28713289 PMC: 5491678. DOI: 10.3389/fphys.2017.00460.


Mitochondrial miRNAs in diabetes: just the tip of the iceberg.

Baradan R, Hollander J, Das S Can J Physiol Pharmacol. 2017; 95(10):1156-1162.

PMID: 28467860 PMC: 5854153. DOI: 10.1139/cjpp-2016-0580.


Divergent Effects of miR-181 Family Members on Myocardial Function Through Protective Cytosolic and Detrimental Mitochondrial microRNA Targets.

Das S, Kohr M, Dunkerly-Eyring B, Lee D, Bedja D, Kent O J Am Heart Assoc. 2017; 6(3).

PMID: 28242633 PMC: 5524005. DOI: 10.1161/JAHA.116.004694.


References
1.
Murphy E, Steenbergen C . Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin Ther Targets. 2005; 9(3):447-56. DOI: 10.1517/14728222.9.3.447. View

2.
Grover G, Atwal K, Sleph P, Wang F, Monshizadegan H, Monticello T . Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. Am J Physiol Heart Circ Physiol. 2004; 287(4):H1747-55. DOI: 10.1152/ajpheart.01019.2003. View

3.
Steenbergen C, Perlman M, London R, Murphy E . Mechanism of preconditioning. Ionic alterations. Circ Res. 1993; 72(1):112-25. DOI: 10.1161/01.res.72.1.112. View

4.
Imahashi K, Schneider M, Steenbergen C, Murphy E . Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res. 2004; 95(7):734-41. DOI: 10.1161/01.RES.0000143898.67182.4c. View

5.
Ruiz-Meana M, Abellan A, Miro-Casas E, Garcia-Dorado D . Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Res Cardiol. 2007; 102(6):542-52. DOI: 10.1007/s00395-007-0675-y. View